このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
Pieris Pharmaceuticals 過去の業績
過去 基準チェック /06
Pieris Pharmaceuticalsは1%の年平均成長率で業績を伸ばしているが、Biotechs業界はgrowingで15.5%毎年増加している。売上は減少しており、年平均3%の割合である。
主要情報
1.0%
収益成長率
11.0%
EPS成長率
Biotechs 業界の成長 | 17.0% |
収益成長率 | -3.0% |
株主資本利益率 | -74.0% |
ネット・マージン | -39.7% |
前回の決算情報 | 31 Mar 2024 |
最近の業績更新
Recent updates
Why Investors Shouldn't Be Surprised By Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) 27% Share Price Plunge
Apr 21We Think Pieris Pharmaceuticals (NASDAQ:PIRS) Needs To Drive Business Growth Carefully
Mar 19Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Not Doing Enough For Some Investors As Its Shares Slump 27%
Dec 18We Think Pieris Pharmaceuticals (NASDAQ:PIRS) Needs To Drive Business Growth Carefully
Aug 18Analysts Just Shaved Their Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Forecasts Dramatically
May 15Why Investors Shouldn't Be Surprised By Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) 41% Share Price Plunge
Apr 17Can Pieris Pharmaceuticals (NASDAQ:PIRS) Afford To Invest In Growth?
Dec 31Bearish: This Analyst Is Revising Their Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Revenue and EPS Prognostications
Aug 10Pieris Pharmaceuticals GAAP EPS of -$0.14 misses by $0.03, revenue of $3.7M misses by $6.77M
Aug 04Pieris: Early Stage Developer Of Novel Asset Class
Jan 09We're Not Very Worried About Pieris Pharmaceuticals' (NASDAQ:PIRS) Cash Burn Rate
Dec 15Progress At Pieris Pharmaceuticals
Oct 27Analysts Just Made A Noticeable Upgrade To Their Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Forecasts
Aug 05We Think Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) CEO Compensation Package Needs To Be Put Under A Microscope
Jun 19Need To Know: Analysts Just Made A Substantial Cut To Their Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) Estimates
May 22Will Pieris Pharmaceuticals (NASDAQ:PIRS) Spend Its Cash Wisely?
May 19Analysts Are Betting On Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS) With A Big Upgrade This Week
Apr 01Here's What Pieris Pharmaceuticals, Inc.'s (NASDAQ:PIRS) Shareholder Ownership Structure Looks Like
Mar 08We're Keeping An Eye On Pieris Pharmaceuticals' (NASDAQ:PIRS) Cash Burn Rate
Feb 01How Much Did Pieris Pharmaceuticals'(NASDAQ:PIRS) Shareholders Earn From Share Price Movements Over The Last Three Years?
Dec 28How Does Pieris Pharmaceuticals' (NASDAQ:PIRS) CEO Salary Compare to Peers?
Dec 02収支内訳
収支内訳
Pieris Pharmaceuticals の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
---|---|---|---|---|
31 Mar 24 | 41 | -16 | 17 | 0 |
31 Dec 23 | 43 | -25 | 17 | 0 |
30 Sep 23 | 47 | -28 | 19 | 0 |
30 Jun 23 | 33 | -27 | 16 | 0 |
31 Mar 23 | 17 | -41 | 16 | 0 |
31 Dec 22 | 26 | -33 | 16 | 0 |
30 Sep 22 | 28 | -35 | 16 | 0 |
30 Jun 22 | 27 | -42 | 17 | 0 |
31 Mar 22 | 27 | -47 | 17 | 0 |
31 Dec 21 | 31 | -46 | 17 | 0 |
30 Sep 21 | 25 | -51 | 16 | 0 |
30 Jun 21 | 24 | -48 | 16 | 0 |
31 Mar 21 | 32 | -38 | 16 | 0 |
31 Dec 20 | 29 | -37 | 17 | 0 |
30 Sep 20 | 45 | -26 | 18 | 0 |
30 Jun 20 | 57 | -15 | 18 | 0 |
31 Mar 20 | 51 | -22 | 18 | 0 |
31 Dec 19 | 46 | -28 | 18 | 0 |
30 Sep 19 | 34 | -36 | 19 | 13 |
30 Jun 19 | 27 | -40 | 18 | 24 |
31 Mar 19 | 33 | -28 | 19 | 34 |
31 Dec 18 | 29 | -27 | 18 | 41 |
30 Sep 18 | 42 | -8 | 21 | 33 |
30 Jun 18 | 38 | -8 | 19 | 28 |
31 Mar 18 | 28 | -18 | 18 | 24 |
31 Dec 17 | 25 | -18 | 18 | 22 |
30 Sep 17 | 10 | -32 | 14 | 23 |
30 Jun 17 | 7 | -31 | 13 | 22 |
31 Mar 17 | 6 | -27 | 11 | 21 |
31 Dec 16 | 6 | -23 | 9 | 19 |
30 Sep 16 | 5 | -19 | 9 | 15 |
30 Jun 16 | 5 | -17 | 9 | 13 |
31 Mar 16 | 4 | -15 | 8 | 10 |
31 Dec 15 | 3 | -14 | 9 | 8 |
30 Sep 15 | 4 | -15 | 10 | 7 |
30 Jun 15 | 4 | -13 | 8 | 6 |
31 Mar 15 | 4 | -13 | 9 | 6 |
31 Dec 14 | 5 | -10 | 7 | 5 |
30 Sep 14 | 6 | -5 | 5 | 5 |
31 Dec 13 | 12 | 0 | 3 | 9 |
質の高い収益: PIRSは現在利益が出ていません。
利益率の向上: PIRSは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: PIRSは利益を出していないが、過去 5 年間で年間1%の割合で損失を削減してきた。
成長の加速: PIRSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: PIRSは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( -14.4% ) と比較することは困難です。
株主資本利益率
高いROE: PIRSは現在利益が出ていないため、自己資本利益率 ( -73.99% ) はマイナスです。